Allosteric Transition in Lactose Repressor Protein
乳糖阻遏蛋白的变构转变
基本信息
- 批准号:7928481
- 负责人:
- 金额:$ 4.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2009-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAmino Acid SubstitutionAmino AcidsBehaviorBindingBinding SitesBiochemicalBiologicalC-terminalCharacteristicsChemicalsCommunicationComplexCoupledCrystallizationDNADNA BindingDataEmployee StrikesEnvironmentEventExhibitsFamilyGeneric DrugsGenesGeneticGenetic TranscriptionGoalsHandHomologous GeneIndividualLactoseLibrariesLigand BindingLigandsLinkModelingModificationMolecular ConformationMutationNMR SpectroscopyOrganismPathway interactionsPatternPhysiologicalPropertyProtein FamilyProteinsRecording of previous eventsRegulationRepressor ProteinsResearch PersonnelResolutionRoleSideSignal TransductionSiteSite-Directed MutagenesisStructureSystemTestingTimeLineTranscription Repressor/CorepressorVariantbasebiological systemscomparativeconformational conversiondesigndimerinsightmembermolecular dynamicsmolecular sizemonomermutantnovelprogramsprotein aminoacid sequenceprotein foldingprotein functionprotein structureresearch studyresponsetool
项目摘要
DESCRIPTION (provided by applicant): Biological systems universally employ cascades of binding/catalytic events to transmit information regarding environmental and physiological states. This communication network requires that protein function be altered by allosteric mechanisms. The dearth of atomic level insight into such intramolecular signal transduction motivates our continued studies of the "switching" pathway in the well-studied lactose repressor protein (LacI). In LacI function, ligand binding information must flow through the protein structure between the widely separated inducer and DNA binding sites. Our ultimate goal is an atomic-level view and sequential timeline of the conformational changes that result in release of operator DNA and consequent transcription of downstream genes. We recently used targeted molecular dynamics simulation (TMD) to predict an atomic-level allosteric pathway that is concordant with the large library of experimental data on LacI. Coupled with available phenotypic information, this model provides a unique framework for designing novel experiments to examine and redesign the conformational behavior of LacI and to evaluate TMD as a general tool for deciphering allosteric pathways. Experiments are proposed to examine specific features of LacI: (1) the potential for a single (or only a few) amino acid(s) to trigger allosteric response to inducer; (2) the role of the core N-subdomain interface in adopting the alternate conformations; (3) the regulation of structural shifts by amino acids in the 3-stranded core pivot that links the N- and C-subdomains of the LacI core; and (4) the influence of symmetry on the allosteric response. Site-specific mutagenesis will be used in concert with detailed biophysical analysis (and, where possible, structural data) to assess the role of specific amino acids in the allosteric pathway and the influence of asymmetric amino acid changes within a dimer. LacI provides a unique system with the requisite background of information and tools to test rigorously the predictions of TMD calculations. With established reliability, TMD can be used to more fully exploit the increasing number of end-point structures available for allosteric proteins. Finally, information on allosteric changes in LacI can be integrated with the recent successful design of novel ligand binding activities based on the protein fold common to the LacI core and other protein families. Comprehensive understanding of LacI behavior and function may allow extension of design principles to generate even more complex allosteric systems.
描述(由申请人提供):生物系统普遍采用结合/催化事件的级联来传输有关环境和生理状态的信息。该通信网络要求通过变构机制改变蛋白质功能。原子水平对这种分子内信号转导的洞察力的洞察力激发了我们对良好研究的乳糖抑制剂蛋白(LACI)中“开关”途径的持续研究。在LACI功能中,配体结合信息必须在广泛分离的诱导剂和DNA结合位点之间流过蛋白质结构。我们的最终目标是构象变化的原子级视图和顺序时间表,导致算子DNA的释放以及随之而来的下游基因的转录。我们最近使用靶向分子动力学模拟(TMD)来预测与LACI的大量实验数据库一致的原子级变构途径。加上可用的表型信息,该模型为设计新颖的实验提供了一个独特的框架,以检查和重新设计LACI的构象行为,并评估TMD作为解密变构途径的一般工具。提出了实验来检查LACI的特定特征:(1)单个(或仅几个)氨基酸的潜力触发诱导剂的变构反应; (2)核心n-辅助剂界面在采用替代构象中的作用; (3)在连接LACI核心的N-和C-亚群的3链核心枢轴中对氨基酸的结构转移调节; (4)对称性对变构反应的影响。位点特异性诱变将与详细的生物物理分析(以及可能的结构数据)一起使用,以评估特异性氨基酸在变构途径中的作用以及二聚体内不对称氨基酸变化的影响。 LACI提供了一个独特的系统,具有必要的信息和工具背景,以严格测试TMD计算的预测。有了既定的可靠性,TMD可用于更充分利用可用于变构蛋白的端点结构的增加。最后,基于LACI核心和其他蛋白质家族共有的蛋白质折叠的新型配体结合活性的新型配体结合活性的设计,可以将有关LACI的变构变化的信息整合在一起。对LACI行为和功能的全面了解可能会使设计原理的扩展能够产生更复杂的变构系统。
项目成果
期刊论文数量(59)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Thermodynamic analysis of the lactose repressor-operator DNA interaction.
乳糖阻遏蛋白-操纵基因 DNA 相互作用的热力学分析。
- DOI:10.1021/bi00361a017
- 发表时间:1986
- 期刊:
- 影响因子:2.9
- 作者:Whitson,PA;Olson,JS;Matthews,KS
- 通讯作者:Matthews,KS
Wild-type operator binding and altered cooperativity for inducer binding of lac repressor dimer mutant R3.
野生型操纵基因结合和 lac 阻遏物二聚体突变体 R3 诱导剂结合的协同性改变。
- DOI:
- 发表时间:1994
- 期刊:
- 影响因子:0
- 作者:Chen,J;Alberti,S;Matthews,KS
- 通讯作者:Matthews,KS
Influence of supercoiling and sequence context on operator DNA binding with lac repressor.
超螺旋和序列背景对操纵子 DNA 与 lac 阻遏物结合的影响。
- DOI:
- 发表时间:1987
- 期刊:
- 影响因子:0
- 作者:Whitson,PA;Hsieh,WT;Wells,RD;Matthews,KS
- 通讯作者:Matthews,KS
Trp repressor interaction with bromodeoxyuridine-substituted operators alters UV-induced perturbation pattern in a sequence-dependent manner.
Trp 阻遏蛋白与溴脱氧尿苷取代操纵子的相互作用以序列依赖性方式改变紫外线诱导的扰动模式。
- DOI:10.1021/bi00091a002
- 发表时间:1993
- 期刊:
- 影响因子:2.9
- 作者:Liu,YC;Matthews,KS
- 通讯作者:Matthews,KS
Diethyl pyrocarbonate reaction with the lactose repressor protein affects both inducer and DNA binding.
焦碳酸二乙酯与乳糖阻遏蛋白的反应影响诱导剂和 DNA 结合。
- DOI:10.1021/bi00407a005
- 发表时间:1988
- 期刊:
- 影响因子:2.9
- 作者:Sams,CF;Matthews,KS
- 通讯作者:Matthews,KS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHLEEN S MATTHEWS其他文献
KATHLEEN S MATTHEWS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHLEEN S MATTHEWS', 18)}}的其他基金
PURCHASE OF FERMENTER AND OLIGONUCLEOTIDE SYNTHESIZER
发酵机和寡核苷酸合成仪的购买
- 批准号:
3519312 - 财政年份:1986
- 资助金额:
$ 4.61万 - 项目类别:
MUTANTS OF REPRESSOR AND PERIPLASMIC BINDING PROTEINS
阻遏蛋白和周质结合蛋白的突变体
- 批准号:
3287296 - 财政年份:1985
- 资助金额:
$ 4.61万 - 项目类别:
MUTANTS OF REPRESSOR AND PERIPLASMIC BINDING PROTEINS
阻遏蛋白和周质结合蛋白的突变体
- 批准号:
3287297 - 财政年份:1985
- 资助金额:
$ 4.61万 - 项目类别:
MUTANTS OF REPRESSOR AND PERIPLASMIC BINDING PROTEINS
阻遏蛋白和周质结合蛋白的突变体
- 批准号:
3287298 - 财政年份:1985
- 资助金额:
$ 4.61万 - 项目类别:
相似国自然基金
吡喃糖骨架双功能催化剂设计及其应用于α-四取代碳-α-氨基酸衍生物的不对称催化合成
- 批准号:22361009
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
氟取代氨基酸修饰P450DA单加氧酶合成手性β-卤代醇的研究
- 批准号:32060215
- 批准年份:2020
- 资助金额:33 万元
- 项目类别:地区科学基金项目
氟代烷基取代的Cα-季碳氨基酸的不对称催化合成研究
- 批准号:21901074
- 批准年份:2019
- 资助金额:26.5 万元
- 项目类别:青年科学基金项目
功能化氮取代聚氨基酸的设计合成与性质研究
- 批准号:21704050
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
靶向肿瘤氨基酸转运体N-取代氨基酸PET显像剂的研制及其作用机理研究
- 批准号:81371584
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
The role of Septin6 Group in Murine and Human Hematopoiesis
Septin6 组在小鼠和人类造血中的作用
- 批准号:
10718515 - 财政年份:2023
- 资助金额:
$ 4.61万 - 项目类别:
ePIMAX-RCR: Controlled expression of post-translationally modified proteins in eukaryotes
ePIMAX-RCR:真核生物中翻译后修饰蛋白的受控表达
- 批准号:
10095625 - 财政年份:2020
- 资助金额:
$ 4.61万 - 项目类别:
ePIMAX-RCR: Controlled expression of post-translationally modified proteins in eukaryotes
ePIMAX-RCR:真核生物中翻译后修饰蛋白的受控表达
- 批准号:
10263311 - 财政年份:2020
- 资助金额:
$ 4.61万 - 项目类别:
O-GlcNAc dynamics and the OGT interactome in variants causal for X-linked intellectual disability
导致 X 连锁智力障碍的变异中的 O-GlcNAc 动力学和 OGT 相互作用组
- 批准号:
10011894 - 财政年份:2019
- 资助金额:
$ 4.61万 - 项目类别:
Investigating the VapBC family of toxin-antitoxin systems in Mycobacterium tuberculosis
研究结核分枝杆菌毒素-抗毒素系统的 VapBC 家族
- 批准号:
9467771 - 财政年份:2017
- 资助金额:
$ 4.61万 - 项目类别: